首页> 外文学位 >Membrane forces and key protein determinants of hematopoietic cell function: Lamins and myosin-II in hematopoiesis and CD47 in immunotherapy of cancer.
【24h】

Membrane forces and key protein determinants of hematopoietic cell function: Lamins and myosin-II in hematopoiesis and CD47 in immunotherapy of cancer.

机译:造血细胞功能的膜力和关键蛋白决定因素:造血细胞中的Lamins和Myosin-II和癌症免疫疗法中的CD47。

获取原文
获取原文并翻译 | 示例

摘要

Hematopoiesis in human bone marrow generates every second about 10 5--106 anucleated platelets and red blood cells as well as nucleated white blood cells that are capable of infiltrating distant tissues. The thesis begins in the marrow with a description of (1) nuclear membrane 'lamina' physicochemical properties that influence marrow-to-circulation trafficking, and proceeds to detail (2) the physicochemical roles of membrane cortex 'myosin' in key marrow processes of motility and division as well as platelet biogenesis and disease. The thesis finishes with (3) studies of macrophages in peripheral tissues far from the marrow and aspects of how such cells distinguish 'foreign' cells from 'self' cells.;Collaborative studies show the lamin-A:B ratio controls nuclear viscoelasticity and in turn cell trafficking relevant to marrow escape. Additionally, differential lamin expression can direct erythroid and megakaryocyte differentiation. Secondly, xenografts show that MIIB is required for blood cell generation, while MIIA is required for long-term HSC/P engraftment. MII inhibition by blebbistatin prior to xenotransplantation enriches for long-term hematopoietic multilineage reconstituting cells, and also multi-nucleated megakaryocytes. Cone and plate rheometry demonstrates an optimal shear stress for platelet-like-particle generation from MKs that is enhanced by MII inhibition, and that MIIA heavy chain phosphorylation at S1943 is shear sensitive. Micropipette aspiration of MKs with mutations of the MIIA gene, MYH9, recapitulates MYH9-RD macrothrombocytopenia. Comparing MYH9-RD patient and normal donor platelets shows a similarity in pre/pro-platelets when normals are treated with blebbistatin. These findings provide evidence that regulation of MIIA activity through S1943 phosphorylation is critical to proper MK fragmentation and proplatelet fission to generate platelets of normal size and number.;The dissertation concludes with an investigation of an immunotherapy approach to treat peripheral solid tumors by controlling tumor cell CD47 expression and administering an anti-human polyclonal IgG antibody. These in vivo xenograft models provide a mechanism of selective tumor clearance driven by FcR stimulation of macrophages. In all, this work highlights biophysical factors of cortical and nuclear membranes that govern hematopoietic differentiation and trafficking, normal and pathological thrombopoiesis, and a mechanism of phagocytic clearance of cancer cells through CD47 attenuation and species specific but epitope non-specific antibody infusion.
机译:人骨髓中的造血作用每秒钟产生约10个5--106无核的血小板和红细胞以及能渗透到远处组织的有核白细胞。本论文从对骨髓的描述开始(1)影响骨髓向循环运输的核膜“层状”理化性质,并继续详述(2)膜皮质“肌球蛋白”在小鼠骨髓关键过程中的理化作用。活力和分裂以及血小板的生物发生和疾病。 (3)研究远离骨髓的外周组织中的巨噬细胞,以及这些细胞如何区分“外来”细胞与“自身”细胞的各个方面。协同研究表明,lamin-A:B比率控制着核的粘弹性,并且转向与骨髓逃逸有关的细胞运输。此外,差异性核纤层蛋白表达可以指导红系和巨核细胞分化。其次,异种移植表明,MIIB是血细胞生成所必需的,而MIIA是长期HSC / P移植所必需的。在异种移植之前,blebbistatin对MII的抑制作用丰富了长期造血多谱系重构细胞,以及多核巨核细胞。锥板流变仪显示出通过MII抑制增强了MK生成血小板样颗粒的最佳剪切应力,并且S1943处的MIIA重链磷酸化对剪切敏感。带有MIIA基因MYH9突变的MK的微量移液管抽吸可概括MYH9-RD大血小板减少症。当用珠光抑素治疗正常人时,比较MYH9-RD患者和正常供者的血小板在前/前血小板中显示相似性。这些发现提供了证据,表明通过S1943磷酸化来调节MIIA活性对于适当的MK片段化和血小板原裂以产生正常大小和数量的血小板至关重要。本论文以通过控制肿瘤细胞治疗周围实体瘤的免疫疗法方法作为研究的结尾CD47表达并施用抗人多克隆IgG抗体。这些体内异种移植模型提供了由巨噬细胞的FcR刺激驱动的选择性肿瘤清除机制。总而言之,这项工作强调了控制造血分化和运输,正常和病理性血小板生成以及通过CD47减毒和物种特异性但表位非特异性抗体输注吞噬清除癌细胞的机制的皮层和核膜的生物物理因素。

著录项

  • 作者

    Spinler, Kyle Richard.;

  • 作者单位

    University of Pennsylvania.;

  • 授予单位 University of Pennsylvania.;
  • 学科 Engineering Chemical.;Health Sciences Oncology.;Biology Cell.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 220 p.
  • 总页数 220
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号